These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 15830313

  • 1. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
    Richter J, Schwarz U, Duwe S, Ellerbrok H, Poggensee G, Pauli G.
    Dtsch Med Wochenschr; 2005 Apr 22; 130(16):1007-10. PubMed ID: 15830313
    [Abstract] [Full Text] [Related]

  • 2. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
    Jeyamani R, Joseph AJ, Chacko A.
    Trop Gastroenterol; 2007 Apr 22; 28(4):176-7. PubMed ID: 18416349
    [Abstract] [Full Text] [Related]

  • 3. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, Sakugawa H, Kinjo F, Fujita J.
    Am J Trop Med Hyg; 2006 Feb 22; 74(2):246-9. PubMed ID: 16474078
    [Abstract] [Full Text] [Related]

  • 4. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM, Da Fonseca Porto A.
    Parasite Immunol; 2004 Feb 22; 26(11-12):487-97. PubMed ID: 15771684
    [Abstract] [Full Text] [Related]

  • 5. Case Report: Strongyloides stercoralis Hyperinfection in a Patient with HTLV-1: An Infection with Filariform and Rhabditiform Larvae, Eggs, and Free-Living Adult Females Output.
    De Souza JN, Soares BNRR, Goes LL, Lima CS, Barreto NMPV, Jacobina BS, Gonçalves N, Teixeira MCA, Galvão-Castro B, Grassi MFR, Soares NM.
    Am J Trop Med Hyg; 2018 Dec 22; 99(6):1583-1586. PubMed ID: 30277207
    [Abstract] [Full Text] [Related]

  • 6. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
    Peters L, McCarthy AE, Faught C.
    Int J Infect Dis; 2009 Nov 22; 13(6):e501-3. PubMed ID: 19501008
    [Abstract] [Full Text] [Related]

  • 7. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
    Porto MA, Alcântara LM, Leal M, Castro N, Carvalho EM.
    Am J Trop Med Hyg; 2005 Feb 22; 72(2):124-5. PubMed ID: 15741545
    [Abstract] [Full Text] [Related]

  • 8. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C, Kinoshita K, Nozaki Y, Funauchi M.
    BMC Infect Dis; 2020 Jul 02; 20(1):470. PubMed ID: 32615937
    [Abstract] [Full Text] [Related]

  • 9. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
    Arch EL, Schaefer JT, Dahiya A.
    Dermatol Online J; 2008 Dec 15; 14(12):6. PubMed ID: 19265619
    [Abstract] [Full Text] [Related]

  • 10. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
    Einsiedel L, Fernandes L.
    Intern Med J; 2008 Sep 15; 38(9):697-703. PubMed ID: 19143887
    [Abstract] [Full Text] [Related]

  • 11. Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient.
    Martin SJ, Cohen PR, MacFarlane DF, Grossman ME.
    Skinmed; 2011 Sep 15; 9(3):199-202. PubMed ID: 21675505
    [Abstract] [Full Text] [Related]

  • 12. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
    Pornsuriyasak P, Niticharoenpong K, Sakapibunnan A.
    Southeast Asian J Trop Med Public Health; 2004 Sep 15; 35(3):531-4. PubMed ID: 15689061
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis].
    Ordóñez LE, Angulo ES.
    Biomedica; 2004 Mar 15; 24(1):33-41. PubMed ID: 15239599
    [Abstract] [Full Text] [Related]

  • 14. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
    Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, Takara M.
    Southeast Asian J Trop Med Public Health; 2000 Mar 15; 31(1):147-51. PubMed ID: 11023084
    [Abstract] [Full Text] [Related]

  • 15. Strongyloides stercoralis colitis in a patient positive for human T-cell leukaemia virus with rheumatoid arthritis during an anti-rheumatic therapy: a case report.
    Hashiba Y, Umekita K, Minami H, Kawano A, Nagayasu E, Maruyama H, Hidaka T, Okayama A.
    Mod Rheumatol Case Rep; 2021 Jan 15; 5(1):16-21. PubMed ID: 32772699
    [Abstract] [Full Text] [Related]

  • 16. [An overview of Strongyloides stercoralis and its infections].
    Ardiç N.
    Mikrobiyol Bul; 2009 Jan 15; 43(1):169-77. PubMed ID: 19334396
    [Abstract] [Full Text] [Related]

  • 17. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
    Satoh M, Toma H, Sugahara K, Etoh K, Shiroma Y, Kiyuna S, Takara M, Matsuoka M, Yamaguchi K, Nakada K, Fujita K, Kojima S, Hori E, Tanaka Y, Kamihira S, Sato Y, Watanabe T.
    Oncogene; 2002 Apr 11; 21(16):2466-75. PubMed ID: 11971181
    [Abstract] [Full Text] [Related]

  • 18. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
    Lambertucci JR, Leão FC, Barbosa AJ.
    Rev Soc Bras Med Trop; 2003 Apr 11; 36(4):541-2. PubMed ID: 12937738
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
    Freites A.
    Invest Clin; 2008 Dec 11; 49(4):455-6. PubMed ID: 19245164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.